药群论坛

 找回密码
 立即注册

只需一步,快速开始

查看: 1133|回复: 2
打印 上一主题 下一主题

[新药快讯] 浮米每周文献快讯:2014年11月(二)

[复制链接]
跳转到指定楼层
楼主
xiaoxiao 发表于 2014-11-25 19:28:24 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式

马上注册,结交更多好友,享用更多功能,让你轻松玩转社区

您需要 登录 才可以下载或查看,没有帐号?立即注册  

x
浮米每周文献快讯:2014年11月(二) 作者:浮米网 来源:浮米网  2014-11-24
1. Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform
Bioorganic & Medicinal Chemistry Letters 24 (2014) 5450–5454
doi:10.1016/j.bmcl.2014.10.022
公司/组织:Takeda Pharmaceuticals
候选药物化学结构式/活性:
靶点/作用机制:HDAC6抑制剂
摘要原文:
Acyl derivatives of 4-(aminomethyl)-N-hydroxybenzamide are potent sub-type selective HDAC6 inhibitors. Constrained heterocyclic analogs based on 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine show further enhanced HDAC6 selectivity and inhibitory activity in cells. Homology models suggest that the heterocyclic spacer can more effectively access the wider catalytic channel of HDAC6 compared to other HDAC sub-types.
备注:
HDAC6的底物包括α微管蛋白、皮动蛋白以及Hsp90,介导在肿瘤发生、生长和转移中的重要细胞功能,还与自噬相关。
2. Discovery of potent iminoheterocycle BACE1 inhibitors
Bioorganic & Medicinal Chemistry Letters 24 (2014) 5455–5459
doi:10.1016/j.bmcl.2014.10.006
公司/组织:默克
候选药物化学结构式/活性:
靶点/作用机制:β位淀粉样前体蛋白分泌酶BACE1抑制剂
摘要原文:
The synthesis of a series of iminoheterocycles and their structure–activity relationships (SAR) as inhibitors of the aspartyl protease BACE1 will be detailed. An effort to access the S3 subsite directly from the S1 subsite initially yielded compounds with sub-micromolar potency. A subset of compounds from this effort unexpectedly occupied a different binding site and displayed excellent BACE1 affinities. Select compounds from this subset acutely lowered Aβ40 levels upon subcutaneous and oral administration to rats.
备注:
用于治疗阿尔兹海默病。
3. The discovery of avanafil for the treatment of erectile dysfunction: A novel pyrimidine-5-carboxamide derivative as a potent and highly selective phosphodiesterase 5 inhibitor
Bioorganic & Medicinal Chemistry Letters 24 (2014) 5460–5465
doi:10.1016/j.bmcl.2014.10.008
公司/组织:Mitsubishi Tanabe Pharma Corporation田边三菱制药株式会社
候选药物化学结构式/活性:
靶点/作用机制:磷酸二酯酶-5(PDE5)抑制剂
摘要原文:
Novel pyrimidine-5-carboxamide derivatives bearing a 3-chloro-4-methoxybenzylamino group at the 4-position were identified as potent and highly selective phosphodiesterase 5 inhibitors. Among them, we successfully found 10j (avanafil) which exhibited a potent relaxant effect on isolated rabbit cavernosum (EC30 = 2.1 nM) and a high isozyme selectivity.
备注:
许多口服PDE5抑制剂已被用于治疗性功能障碍ED的一线治疗。
4.  Novel tricyclic pyrazolopyrimidines as potent and selective GPR119 agonists
doi:10.1016/j.bmcl.2014.10.010
公司/组织:诺华
候选药物化学结构式/活性:
靶点/作用机制:GPR119激动剂
摘要原文:
Systematic SAR optimization of the GPR119 agonist lead 1, derived from an internal HTS campaign, led to compound 29. Compound 29 displays significantly improved in vitro activity and oral exposure, leading to GLP1 elevation in acutely dosed mice and reduced glucose excursion in an OGTT study in rats at doses ⩾10 mg/kg.
备注:
5. The effect of pKa on pyrimidine/pyridine-derived histamine H4 ligands
Bioorganic & Medicinal Chemistry Letters 24 (2014) 5489–5492
doi:10.1016/j.bmcl.2014.10.013
公司/组织:杨森
候选药物化学结构式/活性:
靶点/作用机制:组胺H4受体拮抗剂
摘要原文:
During the course of our efforts toward the discovery of human histamine H4 antagonists from a series of 2-aminiopyrimidines, it was noted that a 6-trifluoromethyl group dramatically reduced affinity of the series toward the histamine H4 receptor. This observation was further investigated by synthesizing a series of ligands that varied in pKa of the pyrimidine derived H4 ligands by over five orders of magnitude and the effect on histamine H4 affinity. This trend was then extended to the discovery of C-linked piperidinyl-2-amino pyridines as histamine H4 receptor antagonists.
备注:
6. 2-Aminopyrimidin-4(1H)-one as the novel bioisostere of urea: Discovery of novel and potent CXCR2 antagonists
doi:10.1016/j.bmcl.2014.10.003
公司/组织:GSK
候选药物化学结构式/活性:
靶点/作用机制:CXCR2拮抗剂
摘要原文:
2-Aminopyrimidin-4(1H)-one was proposed as the novel bioisostere of urea. Bioisosteric replacement of the reported urea series of the CXCR2 antagonists with 2-aminopyrimidin-4(1H)-ones led to the discovery of the novel and potent CXCR2 antagonist 3e. 2-Aminopyrimidin-4(1H)-one derivative 3e demonstrated a good developability profile (reasonable solubility and high permeability) and superior chemical stability especially in simulated gastric fluid (SGF) compared with ureas.
备注:
CXCR2拮抗剂被用于治疗COPD、急性呼吸窘迫综合征和风湿性关节炎等免疫疾病。
7. 7-(4-Alkylidenylpiperidinyl)-quinolone bacterial topoisomerase inhibitors
Bioorganic & Medicinal Chemistry Letters 24 (2014) 5502–5506
doi:10.1016/j.bmcl.2014.10.014
公司/组织:杨森
候选药物化学结构式/活性:
靶点/作用机制:细菌拓扑异构酶抑制剂
摘要原文:
Novel antibacterial fluoroquinolone agents bearing a 4-alkylidenylpiperidine 7-position substituent are active against quinolone-susceptible and quinolone-resistant gram-positive bacteria, including Streptococcus pneumoniae and MRSA. Analogs 22b, 23c, and 24 demonstrated superior in vitro and in vivo efficacy to ciprofloxacin against these cocci.
备注:
喹诺酮类被广泛用于抗菌药物。

回复

使用道具 举报

沙发
feibing 发表于 2014-11-25 22:09:48 | 只看该作者
不错的资料,抢沙发了
回复 支持 反对

使用道具 举报

板凳
淡淡654321 发表于 2014-11-25 22:12:01 | 只看该作者
博大精深呀
回复 支持 反对

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册  

本版积分规则

QQ|手机版|药群论坛 ( 蜀ICP备15007902号 )

GMT+8, 2025-7-10 06:59 AM , Processed in 0.090570 second(s), 18 queries .

本论坛拒绝任何人以任何形式在本论坛发表与中华人民共和国法律相抵触的言论! X3.2

© 2011-2014 免责声明:药群网所有内容仅代表发表者个人观点,不代表本论坛立场。

快速回复 返回顶部 返回列表